Long-term results with lanreotide in patients with recurrent gastrointestinal angiodysplasias bleeding or obscure gastrointestinal bleeding. Benefits in efficacy and procedures consumption

2018 ◽  
Vol 53 (12) ◽  
pp. 1496-1502 ◽  
Author(s):  
Santiago Frago ◽  
Javier Alcedo ◽  
Edgar Martín Pena-Galo ◽  
María Lázaro ◽  
Leticia Ollero ◽  
...  
2006 ◽  
Vol 63 (5) ◽  
pp. AB91
Author(s):  
Larry Lai ◽  
Grace Wong ◽  
Dorothy Chow ◽  
James Lau ◽  
Joseph Sung ◽  
...  

2009 ◽  
Vol 23 (9) ◽  
pp. 625-631 ◽  
Author(s):  
Majid Almadi ◽  
Peter M Ghali ◽  
Andre Constantin ◽  
Jacques Galipeau ◽  
Andrew Szilagyi

The present article describes three difficult cases of recurrent bleeding from obscure causes, followed by a review of the pitfalls and pharmacological management of obscure gastrointestinal bleeding. All three patients underwent multiple investigations. An intervening complicating diagnosis or antiplatelet drugs may have compounded long-term bleeding in two of the cases. A bleeding angiodysplasia was confirmed in one case but was aggravated by the need for anticoagulation. After multiple transfusions and several attempts at endoscopic management in some cases, long-acting octreotide was associated with decreased transfusion requirements and increased hemoglobin levels in all three cases, although other factors may have contributed in some. In the third case, however, the addition of low-dose thalidomide stopped bleeding for a period of at least 23 months.


2013 ◽  
Vol 77 (5) ◽  
pp. AB273-AB274 ◽  
Author(s):  
Jin Su Kim ◽  
Chul-Hyun Lim ◽  
Jae Myung Park ◽  
in Seok Lee ◽  
Sang Woo Kim ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Alexander F. Hagel ◽  
Heinz Albrecht ◽  
Andreas Nägel ◽  
Francesco Vitali ◽  
Marcel Vetter ◽  
...  

Introduction. Gastrointestinal bleeding represents the main indication for emergency endoscopy (EE). Lately, several hemostatic powders have been released to facilitate EE.Methods. We evaluated all EE in which Hemospray was used as primary or salvage therapy, with regard to short- and long-term hemostasis and complications.Results. We conducted 677 EE in 474 patients (488 examinations in 344 patients were upper GI endoscopies). Hemospray was applied during 35 examinations in 27 patients (19 males), 33 during upper and 2 during lower endoscopy. It was used after previous treatment in 21 examinations (60%) and in 14 (40%) as salvage therapy. Short-term success was reached in 34 of 35 applications (97.1%), while long-term success occurred in 23 applications (65.7%). Similar long-term results were found after primary application (64,3%) or salvage therapy (66,7%). Rebleeding was found in malignant and extended ulcers. One major adverse event (2.8%) occurred with gastric perforation after Hemospray application.Discussion. Hemospray achieved short-term hemostasis in virtually all cases. The long-term effect is mainly determined by the type of bleeding source, but not whether it was applied as first line or salvage therapy. But, even in the failures, patients had benefit from hemodynamic stabilization and consecutive interventions in optimized conditions.


Sign in / Sign up

Export Citation Format

Share Document